Table 4 Characteristics of obese without diabetes participants before and after exercise (n = 20).
From: Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes
Obese without diabetes (pre) | Obese without diabetes (post) | Variation | P values | |
|---|---|---|---|---|
BMI (kg/m2) | 34.3 ± 3.0 | 33.9 ± 3.8 | − 0.44 ± 0.64 | 0.196 |
Waist (cm) | 104.0 ± 7.6 | 101.0 ± 6.2 | − 2.93 ± 2.24 | 0.102 |
Hip (cm) | 114.8 ± 8.2 | 111.7 ± 9.3 | − 3.05 ± 2.17 | 0.135 |
PBF (%) | 39.0 ± 4.4 | 37.8 ± 5.5 | − 1.21 ± 1.77 | 0.037 |
WBC10 | 5.9 ± 1.9 | 5.7 ± 1.7 | − 0.17 ± 1.18 | 0.627 |
SBP (mmHg) | 115.0 ± 8.2 | 114.5 ± 6.9 | − 0.50 ± 3.44 | 0.627 |
DBP (mmHg) | 75.0 ± 5.3 | 75.0 ± 5.8 | 0.03 ± 1.82 | 1.000 |
Resting HR (beats/min) | 80.3 ± 8.7 | 78.6 ± 13.6 | − 1.70 ± 9.78 | 0.596 |
VO2, max (ml/kg/min) | 17.1 ± 3.7 | 19.8 ± 4.9 | 2.65 ± 3.15 | 0.026 |
TC (mmol/l) | 5.2 ± 1.1 | 5.1 ± 1.2 | − 0.11 ± 0.68 | 0.499 |
HDL (mmol/l) | 1.3 ± 0.3 | 1.3 ± 0.5 | − 0.05 ± 0.26 | 0.434 |
LDL (mmol/l) | 3.5 ± 1.0 | 3.2 ± 1.0 | − 0.24 ± 0.64 | 0.127 |
TG (mmol/l) | 1.1 ± 0.4 | 1.3 ± 0.9 | 0.20 ± 0.87 | 0.159 |
FBG (mmol/l) | 5.3 ± 0.8 | 5.5 ± 1.1 | 0.16 ± 0.64 | 0.308 |
HbA1c (%) | 5.9 ± 1.7 | 5.7 ± 0.5 | − 0.20 ± 1.28 | 0.201 |
Insulin (ng/ml) | 4.1 ± 2.7 | 3.2 ± 1.6 | − 1.06 ± 2.63 | 0.039 |
C-peptide (ng/ml) | 8.8 ± 12.1 | 6.3 ± 7.2 | − 2.53 ± 3.75 | 0.138 |
HOMA-IR | 1.1 ± 0.6 | 0.8 ± 0.2 | − 0.34 ± 0.75 | 0.070 |
hsCRP (μg/ml) | 5.2 ± 0.9 | 5.7 ± 1.7 | 0.52 ± 2.93 | 0.090 |
